[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4019 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 4019
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to
establish a grant program for provide access to, and training on the
administration of, epinephrine products for law enforcement officers,
and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 17, 2025
Ms. Gillen (for herself and Mr. Garbarino) introduced the following
bill; which was referred to the Committee on the Judiciary
_______________________________________________________________________
A BILL
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to
establish a grant program for provide access to, and training on the
administration of, epinephrine products for law enforcement officers,
and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as ``Gio's Law''.
SEC. 2. LAW ENFORCEMENT ACCESS TO EMERGENCY EPINEPHRINE GRANT PROGRAM.
Title I of the Omnibus Crime Control and Safe Streets Act of 1968
(34 U.S.C. 10101 et seq.) is amended by adding at the end the
following:
``PART PP--LAW ENFORCEMENT ACCESS TO EMERGENCY EPINEPHRINE GRANT
PROGRAM
``SEC. 3061. GRANT AUTHORIZATION.
``The Attorney General is authorized to make grants under this part
to States and units of local government to--
``(1) purchase epinephrine products for use by State,
local, and tribal law enforcement agencies;
``(2) train State, local, and tribal law enforcement
officers, in accordance with the curricula developed or
identified under section 3062.
``SEC. 3062. STANDARDIZED TRAINING.
``Not later than 180 days after the date of enactment of this part,
the Attorney General shall develop a training curricula, or identify
effective existing training curricula, to train law enforcement officer
to--
``(1) recognize the symptoms of an anaphylactic reaction;
and
``(2) correctly administer epinephrine products to any
individual reasonably believed to be having an anaphylactic
reaction.
``SEC. 3063. APPLICATION.
``The chief executive of a State or unit of local government
seeking a grant under this part shall submit to the Attorney General an
application at such time, in such manner, and containing such
information as the Attorney General may reasonably require, including a
certification of the State attorney general of the State, or the State
in which the unit of local government is located, that a law
enforcement officer who is authorized in that jurisdiction to
administer epinephrine products to any individual reasonably believed
to be having an anaphylactic reaction is protected from civil liability
arising from administering such a product.
``SEC. 3064. DEFINITION.
``In this part, the term `epinephrine product' means--
``(1) an epinephrine auto-injector; and
``(2) a product that facilitates the administration of
epinephrine other than by injection.
``SEC. 3065. AUTHORIZATION OF APPROPRIATIONS.
``There is authorized to be appropriated $25,000,000 to carry out
this part for each of fiscal years 2026 through 2030.''.
SEC. 3. REPORT ON ADMINISTRATION OF EPINEPHRINE BY LAW ENFORCEMENT
OFFICERS.
On an annual basis, the Attorney General, acting through the
Director of the Bureau of Justice Statistics, shall submit to Congress
and make publicly available, data on the frequency of the
administration of epinephrine products (as such term is defined in
section 3064 of title I of the Omnibus Crime Control and Safe Streets
Act of 1968) by Federal, State, local, and tribal law enforcement
officers.
SEC. 4. INTERAGENCY PUBLIC AWARENESS AND OUTREACH CAMPAIGN.
Not later than 180 days after the date of enactment of this Act,
the Attorney General, in collaboration with the Secretary of Health and
Human Services, shall design and implement a public awareness campaign
to educate members of the public about--
(1) the symptoms of an anaphylactic reaction; and
(2) the role of law enforcement officers and first
responders in administering epinephrine products.
<all>